Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice

Behavioural Brain Research

Volumn 162, Issue 1, 2005, Pages 1-10

  Iancu, Ruxandra ^a   Mohapel, Paul ^a   Brundin, Patrik ^a   Paul, Gesine ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

6 OHDA; Behavioral tests; Mouse model; Parkinson disease; Tyrosine hydroxylase

Indexed keywords

AMPHETAMINE; APOMORPHINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; LOCOMOTION; MOUSE; NONHUMAN; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; ROTATION; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

ADRENERGIC AGENTS; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; CELL COUNT; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; FEMALE; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MEDIAL FOREBRAIN BUNDLE; MICE; MICE, INBRED CBA; MOTOR ACTIVITY; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PSYCHOMOTOR PERFORMANCE; ROTAROD PERFORMANCE TEST; ROTATION; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 19444370500     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.02.023     Document Type: Article

References (57)

1. A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-Lundberg, W.H. Ho, and P.E. Castillo Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 2000 239 252
2. D.N. Abrous, J.J. Rodriguez, M.F. Montaron, C. Aurousseau, M. Le Moal, and P. Barneoud Behavioural recovery after unilateral lesion of the dopaminergic mesotelencephalic pathway: effect of repeated testing Neuroscience 84 1998 213 221
3. T. Archer, T. Palomo, R. McArthur, and A. Fredriksson Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment Neurotoxicol Res 5 2003 95 110
4. M. Asanuma, N. Ogawa, S. Nishibayashi, M. Kawai, Y. Kondo, and E. Iwata Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine- lesioned mouse brain Arch Int Pharmacodyn Ther 329 1995 221 230
5. J.H. Baik, R. Picetti, A. Saiardi, G. Thiriet, A. Dierich, and A. Depaulis Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors Nature 377 1995 424 428
6. J.C. Bensadoun, N. Deglon, J.L. Tseng, J.L. Ridet, A.D. Zurn, and P. Aebischer Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF Exp Neurol 164 2000 15 24
7. J.C. Bensadoun, O. Mirochnitchenko, M. Inouye, P. Aebischer, and A.D. Zurn Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice Eur J Neurosci 10 1998 3231 3236
8. C.V. Borlongan, and P.R. Sanberg Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism J Neurosci 15 1995 5372 5378
9. P. Brundin, O. Isacson, F.H. Gage, A. Prochiantz, and A. Bjorklund The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting Brain Res 366 1986 346 349
10. J.J. Canales, and A.M. Graybiel A measure of striatal function predicts motor stereotypy Nature Neurosci 3 2000 377 383
11. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity Science 197 1977 596 598
12. L.A. Cunningham, and C. Su Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease Exp Neurol 174 2002 230 242
13. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
14. S.B. Dunnett, and A. Bjorklund Prospects for new restorative and neuroprotective treatments in Parkinson's disease Nature 399 1999 A32 A39
15. E. Eidelberg, B.A. Brooks, W.W. Morgan, J.G. Walden, and R.H. Kokemoor Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinsonism in monkeys Neuroscience 18 1986 817 822
16. S. Fahn Description of Parkinson's disease as a clinical syndrome Ann NY Acad Sci 991 2003 1 14
17. P.O. Fernagut, E. Diguet, B. Labattu, and F. Tison A simple method to measure stride length as an index of nigrostriatal dysfunction in mice J Neurosci Methods 113 2002 123 130
18. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press limited
19. G.M. Friehs, R.G. Parker, L.S. He, S.J. Haines, D.A. Turner, and T.J. Ebner Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of Parkinsonism J Neural Transplant Plast 2 1991 141 156
20. M.S. Goldberg, S.M. Fleming, J.J. Palacino, C. Cepeda, H.A. Lam, and A. Bhatnagar Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J Biol Chem 278 2003 43628 43635
21. J.M. Henderson, S. Watson, G.M. Halliday, T. Heinemann, and M. Gerlach Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat Behav Brain Res 139 2003 105 113
22. O. Hornykiewicz The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease Wien Klin Wochenschr 75 1963 309 312
23. J.L. Hudson, C.G. van Horne, I. Stromberg, S. Brock, J. Clayton, and J. Masserano Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats Brain Res 626 1993 167 174
24. J.M. Itier, P. Ibanez, M.A. Mena, N. Abbas, C. Cohen-Salmon, and G.A. Bohme Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Hum Mol Genet 12 2003 2277 2291
25. F. Javoy, C. Sotelo, A. Herbet, and Y. Agid Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system Brain Res 102 1976 201 215
26. B.S. Jeon, V. Jackson-Lewis, and R.E. Burke 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death Neurodegeneration 4 1995 131 137
27. D. Kirik, C. Rosenblad, and A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp Neurol 152 1998 259 277
28. D. Kirik, C. Rosenblad, and A. Bjorklund Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor Eur J Neurosci 12 2000 3871 3882
29. C.S. Lee, H. Sauer, and A. Bjorklund Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat Neuroscience 72 1996 641 653
30. M. Lundblad, M. Andersson, C. Winkler, D. Kirik, N. Wierup, and M.A. Cenci Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur J Neurosci 15 2002 120 132
31. M. Lundblad, B. Picconi, H. Lindgren, and M.A. Cenci A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function Neurobiol Dis 16 2004 110 123
32. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, and A. Takeda Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
33. K. Nishii, N. Matsushita, H. Sawada, H. Sano, Y. Noda, and T. Mamiya Motor and learning dysfunction during postnatal development in mice defective in dopamine neuronal transmission J Neurosci Res 54 1998 450 464
34. G.A. Ricaurte, L.E. DeLanney, K.T. Finnegan, I. Irwin, and J.W. Langston The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging Brain Res 438 1988 395 398
35. D.C. Rogers, E.M. Fisher, S.D. Brown, J. Peters, A.J. Hunter, and J.E. Martin Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment Mamm Genome 8 1997 711 713
36. D.C. Rogers, J. Peters, J.E. Martin, S. Ball, S.J. Nicholson, and A.S. Witherden SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice Neurosci Lett 306 2001 89 92
37. M. Roghani, G. Behzadi, and T. Baluchnejadmojarad Efficacy of elevated body swing test in the early model of Parkinson's disease in rat Physiol Behav 76 2002 507 510
38. D.S. Rothblat, J.A. Schroeder, and J.S. Schneider Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism J Neurosci Res 65 2001 254 266
39. G. Rozas, M.J. Guerra, and J.L. Labandeira-Garcia An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of Parkinsonism Brain Res Brain Res Prot 2 1997 75 84
40. G. Rozas, and J.L. Labandeira Garcia Drug-free evaluation of rat models of Parkinsonism and nigral grafts using a new automated rotarod test Brain Res 749 1997 188 199
41. K. Saigoh, Y.L. Wang, J.G. Suh, T. Yamanishi, Y. Sakai, and H. Kiyosawa Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice Nature Genet 23 1999 47 51
42. T. Schallert, and J.L. Tillerson Intervention strategies for degeneration of dopamine neurons in Parkinsonism: optimizing behavioral assessment of outcome D.F. Emerich R.L.a. Dean P.R. Sanberg Central Nervous System Disease: Innovative Models of CNS Diseases from Molecule to Therapy 2000 Humana Press Totowa, NJ 131 151
43. R.K. Schwarting, and J.P. Huston The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments Prog Neurobiol 50 1996 275 331
44. M. Sedelis, K. Hofele, G.W. Auburger, S. Morgan, J.P. Huston, and R.K. Schwarting Evidence for resistance to MPTP in C57BL/6 × BALB/c F1 hybrids as compared with their progenitor strains Neuroreport 11 2000 1093 1096
45. M. Sedelis, K. Hofele, G.W. Auburger, S. Morgan, J.P. Huston, and R.K. Schwarting MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences Behav Genet 30 2000 171 182
46. M. Sedelis, R.K. Schwarting, and J.P. Huston Behavioral phenotyping of the MPTP mouse model of Parkinson's disease Behav Brain Res 125 2001 109 125
47. E. Sundstrom, A. Fredriksson, and T. Archer Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease Brain Res 528 1990 181 188
48. E. Sundstrom, and E.B. Samuelsson Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents Pharmacol Toxicol 81 1997 226 231
49. N. Takahashi, L.L. Miner, I. Sora, H. Ujike, R.S. Revay, and V. Kostic VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity Proc Natl Acad Sci USA 94 1997 9938 9943
50. J.R. Taylor, J.D. Elsworth, R.H. Roth, J.R. Sladek Jr., and D.E. Redmond Jr. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus) Neuroscience 81 1997 745 755
51. J. Thomas, J. Wang, H. Takubo, J. Sheng, S. de Jesus, and K.S. Bankiewicz A 6-hydroxydopamine-induced selective Parkinsonian rat model: further biochemical and behavioral characterization Exp Neurol 126 1994 159 167
52. J.L. Tillerson, A.D. Cohen, J. Philhower, G.W. Miller, M.J. Zigmond, and T. Schallert Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine J Neurosci 21 2001 4427 4435
53. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res 24 1970 485 493
54. M.J. West, L. Slomianka, and H.J. Gundersen Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator Anat Rec 231 1991 482 497
55. I.Q. Whishaw, K. Li, P.A. Whishaw, B. Gorny, and G.A. Metz Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking J Neurosci Methods 126 2003 13 23
56. H. Widner, P. Brundin, A. Bjorklund, and E. Moller Immunological aspects of neural grafting in the mammalian central nervous system Prog Brain Res 78 1988 303 307
57. M.G. Ziegler, and H. Szechtman Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system Behav Brain Res 39 1990 123 133